Navigation Links
Best way to treat malaria: Avoid using same drug for everyone, scientists say
Date:9/5/2008

A team of scientists employing a sophisticated computer model pioneered at Princeton University and Resources for the Future has found that many governments worldwide are recommending the wrong kind of malaria treatment.

Despite the availability of many drugs and therapies to treat malaria, many countries' national policies recommend using what is known as a single first-line therapy -- that is, using one drug repeatedly with many patients. Writing in the Sept. 16 issue of the Proceedings of the National Academy of Sciences, a team led by Maciej Boni, who conducted the research as a postdoctoral fellow at Princeton and scholar at Resources, a Washington, D.C.-based think tank, reports that countries could cut the death rate and forestall the development of drug resistance if a variety of different drugs were distributed to patients.

This approach, known as multiple first-line therapies or MFT, could be put into place by making sure different drugs cost about the same, so that patients would not be forced into buying the cheapest available drug but would choose from a random pool. Or it could be applied by clinic physicians who could simply alternate their choices for drugs they prescribe to patients.

"What we found is that using multiple first-line therapies is the best way to avoid treatment failures and to delay the development of resistance for as long as possible," said Boni, who recently has joined the staff of the Oxford University Clinical Research Unit in Ho Chi Minh City, Vietnam.

One catch to the researchers' strategy is that multiple effective therapies may not always be available. In some African countries where drug-resistance is already widespread, the only effective therapies are a class of drugs known as artemisinin-based combination therapies (ACTs).

"MFT does not necessarily solve all our problems," said Boni. "Antimalarial drug development needs to continue with the hope of producing novel
'/>"/>

Contact: Kitta MacPherson
kittamac@princeton.edu
609-258-5729
Princeton University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Nicotinic receptors may be important targets for treatment of multiple addictions
2. A new radiation therapy treatment developed for head and neck cancer patients
3. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
4. Gamma globulin effective in treating eye infections caused by adenoviruses
5. Presence of gene mutation helps guide thyroid cancer treatment
6. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
7. New genetic research into nicotine addiction shows promise for personalized treatment
8. Doctors learn to control their own brains pain responses to better treat patients
9. Interleukin-8, key marker for colorectal cancer treatment
10. New class of drug offers hope to treatment-resistant AIDS patients
11. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...asurements of plasma lipoprotein concentrations de...y (NMR), researchers led by Daniel Chasman at Brig...l in Boston, MA, the Framingham Heart Study in Fra..., Sweden and Oxford, England performed genetic ass...,296 women of European ancestry from the Women,s G...
(Date:11/20/2009)...ovember 19, 2009 The estimated 4.6 million Americ... of developing respiratory symptoms due to poor ai...aire study undertaken earlier this year by investi...terinary Medicine. , The studywhich polled more ...0 percent of individuals working in barns complain...
(Date:11/20/2009)...e production of flax shives, and generated from B... to those which engulf fields in spring, can be us...by two studies carried out by Spanish and Dutch re...and Sustainable Energy Reviews . , "These studies...e production of bioethanol from two, as yet unexpl...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Flax and yellow flowers can produce bioethanol 2Amgens Denosumab and Eli Lillys Forteo Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018 47435 1Amgens Denosumab and Eli Lillys Forteo Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018 47435 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 12374 1Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 12374 2Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 12374 3
...e evolutionary paths some 5 million to 6 million y... mastered bipedal locomotion, and acquired a knack...d to use tools, and developed the skills to constr...We differ by just a tad over 1% at the DNA sequenc...should harbor genetic footprints of our divergence...
...n time, what causes those variations, and how sens...orestation is a focus of study for scientists at t...lopment pressures in the last several decades have...Amazon, most in the eastern and southern portion o...odels and data from several disciplines to assess ...
... greenbug or rust in wheat may require some bridge... at the Texas A&M University System Agricultur...reeder, is looking at wild grass species and synth...ng for new unique sources of resistance to various...ng forced to find broader gene pools to bring in t...
Other Biology News:Can our genes tell the story of our divergence? 2Assessing the Amazon River's sensitivity to deforestation 2Wild grasses and man-made wheats advance research capabilities 2Wild grasses and man-made wheats advance research capabilities 3
(Date:11/18/2009)...at Queen,s University Belfast are developing new s... which will help in the fight against the threat o...ial gel pads to ,swipe, an individual or crime sce...scanning instrument that can detect the presence o..., faster decisions to be made in response to terro...
(Date:11/18/2009)... Vernier,s experience in data analysis combined wi...am kits and curricula provide state-of-the...BEAVERTON, Ore., Nov. 18 Vernier S...l science interfaces, sensors, and software and Bi...urer and distributor of life science research and ...
(Date:11/18/2009)...ST GRINSTEAD, West Sussex, U.K. and CLEVELAND, Nov...gellan Biosciences business and premier provider o...or microbiology labs, has expanded its East Grinst...ent facility to meet increasing global demand for ...ty and identification testing. The expanded facili...
(Date:11/18/2009)...SISSAUGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM ...fe sciences product development company that ident...g cancer-related products at various stages of dev...uating nimotuzumab were presented today in a poste... Cancer Therapeutics conference in Boston, Massach...
Breaking Biology Technology:New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
... DNA2.0 has designed RNAi-resistant ge...he inner workings of the cell cycle. DNA2.0,s RNAi...ession in the desired host and to escape inhibitio..., Menlo Park, Calif. (PRWE...tic genomics company, announced today that the com...
...akes up nearly 23% of fund raising goal for Centra...ompany,(NYSE: LLY ) President and Chief Executive...million check to the United Way of Central Indiana...aising campaigns. The check,represents the contrib...United States with a matching gift amount from the...
...NG, Pa., Nov. 13 Genaera,Corporation (Nasdaq: GE...vember 17-19 at the Congress Center in Mannheim, G...and Chief Scientific Officer, will present,a compa... a.m. CET., About Genaera, Genaera Corporation i...iabetes and obesity currently in phase 1 clinical ...
Other Biology Technology:RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research 2RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research 3Lilly Contributes $11.1 Million to United Way Annual Campaign 2Genaera to Present at BIO-Europe 2008 2
...d reduced space requirements of the MassARRAY Comp...chnology affordable .The benchtop system can be us... including: ,, High-Performance Genotyp... (QGE) , Quantitative Methylation Analysis ( Epi...
...ncludes all the features of Tracker, plus software...a user defined period of time in a user defined ar...ments all built around a video camera, frame grabb...rack two fields at once and up to 6 moving animals...
...d to distinguish collagen from muscle in tissue sp...The Trichrome stain is often used to differentiate...y an increase in collagenous tissue. With the Arti...ined red, collagen - blue, fibrin - pink, erythroc...
...a score of movement counts, similar to an infrared... 6 subjects at once, in two frames of reference, r...tal group at once, and allow social interaction as...of other spatial behavior situations, including ou...
Biology Products: